Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine Yahoo Finance Nawigacja wpisu New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential – Yahoo Finance Long-time physician Dr. David Scoggin receives Humanitarian Award from FMC – Lancaster Eagle-Gazette
